{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:25:17Z","timestamp":1790630717231,"version":"4.1.0"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T00:00:00Z","timestamp":1477872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>\u2003<\/jats:title><jats:p>Bone loss is a common comorbidity of inflammatory bowel disease (IBD), leading to elevated fracture risk in these patients. Inflammatory factors associated with IBD cause increased bone resorption and decreased bone formation with multiple factors implicated as instigators of these alterations. In this project, we examined the influence of IBD on osteocyte proteins in male rats (2 months old) divided into two groups: induced gut inflammation via 2,4,6-trinitrobenzenesulfonic acid (TNBS) enema, and vehicle control. We examined the prevalence of two pro-inflammatory cytokines, tumor necrosis factor-\u03b1 (TNF-\u03b1) and interleukin-6 (IL-6), an anti-inflammatory cytokine, interleukin-10 (IL-10), the anabolic factor insulin-like growth factor-I (IGF-I), osteoclastogenesis regulators RANKL and OPG, and the bone formation inhibitor sclerostin in osteocytes in three bone compartments 4 weeks after initiation of gut inflammation. Histomorphometry of the proximal tibia and fourth lumbar vertebra revealed lower bone volume, lower bone formation rate (BFR), lower osteoid surface (OS), and higher osteoclast surface (Oc.S) with TNBS. Tibial mid-shaft periosteal BFR was also lower with TNBS. Immunohistochemical staining of the distal femur demonstrated that %TNF-\u03b1+, %IL-6+, %RANKL+, and %OPG+ osteocytes were elevated in cancellous bone in TNBS animals compared to vehicle. These changes were coincident with increased bone resorption. With regression analysis, %RANKL+ osteocytes statistically predicted the increase in cancellous Oc.S (R2\u2009=\u20090.565). Increased %sclerostin+ osteocytes observed in the TNBS treatment predicted declines in cancellous OS (R2\u2009=\u20090.581) as well as BFR in cancellous and cortical bone (R2\u2009=\u20090.674, R2\u2009=\u20090.908, respectively). Contrary to our hypothesis, %IGF-I+ osteocytes increased in TNBS animals. In conclusion, the IBD model produced a systemic inflammation that altered the regulatory protein profile in osteocytes that control bone resorption and bone formation, likely contributing to IBD-induced bone loss. These data highlight a potential mechanistic role of osteocytes in inflammatory bone loss associated with IBD and systemic inflammation. \u00a9 2017 American Society for Bone and Mineral Research.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jbmr.3027","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T14:55:03Z","timestamp":1488293703000},"page":"802-813","source":"Crossref","is-referenced-by-count":59,"title":["Inflammatory Bowel Disease in a Rodent Model Alters Osteocyte Protein Levels Controlling Bone Turnover"],"prefix":"10.1093","volume":"32","author":[{"given":"Corinne E","family":"Metzger","sequence":"first","affiliation":[{"name":"Department of Health and KinesiologyTexas A&M University Health Science CenterCollege StationTXUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Narayanan","sequence":"additional","affiliation":[{"name":"Department of Medical PhysiologyCollege of MedicineTexas A&M UniversityCollege StationTXUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Zawieja","sequence":"additional","affiliation":[{"name":"Department of Medical PhysiologyCollege of MedicineTexas A&M UniversityCollege StationTXUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A","family":"Bloomfield","sequence":"additional","affiliation":[{"name":"Graduate Faculty of NutritionTexas A&M UniversityCollege StationTXUSA"},{"name":"Department of Health and KinesiologyTexas A&M University Health Science CenterCollege StationTXUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"2024021014203442900_jbmr3027-bib-0001","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental issues","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"issue":"3","key":"2024021014203442900_jbmr3027-bib-0002","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/joim.12413","article-title":"The emerging global epidemic of paediatric inflammatory bowel disease\u2014causes and consequences","volume":"279","author":"Malmborg","year":"2016","journal-title":"J Intern Med"},{"key":"2024021014203442900_jbmr3027-bib-0003","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"2024021014203442900_jbmr3027-bib-0004","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/gut.2006.117382","article-title":"Gut, inflammation, and osteoporosis: basic and clinical concepts","volume":"57","author":"Tilg","year":"2008","journal-title":"Gut"},{"issue":"4","key":"2024021014203442900_jbmr3027-bib-0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11914-011-0077-9","article-title":"Bone, inflammation, and inflammatory bowel disease","volume":"9","author":"Agrawal","year":"2011","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"2024021014203442900_jbmr3027-bib-0006","doi-asserted-by":"crossref","first-page":"G191","DOI":"10.1152\/ajpgi.00496.2010","article-title":"Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases","volume":"300","author":"Ghishan","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2024021014203442900_jbmr3027-bib-0007","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02106094","article-title":"Bone loss in patients with inflammatory bowel disease: a prospective study","volume":"5","author":"Roux","year":"1995","journal-title":"Osteoporosis Int"},{"key":"2024021014203442900_jbmr3027-bib-0008","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00054725-199811000-00002","article-title":"Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease","volume":"4","author":"Schulte","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"2024021014203442900_jbmr3027-bib-0009","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ibd.20006","article-title":"Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease","volume":"13","author":"Sylvester","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2024021014203442900_jbmr3027-bib-0010","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","article-title":"Incidence of fracture among patients with inflammatory bowel disease","volume":"133","author":"Bernstein","year":"2000","journal-title":"Ann Intern Med"},{"key":"2024021014203442900_jbmr3027-bib-0011","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1136\/gut.40.2.228","article-title":"Reduced bone density in patients with inflammatory bowel disease","volume":"40","author":"Bjarnason","year":"1997","journal-title":"Gut"},{"issue":"2","key":"2024021014203442900_jbmr3027-bib-0012","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00054725-200203000-00003","article-title":"Risk factors for low bone density in Crohn's disease","volume":"8","author":"Habtezion","year":"2002","journal-title":"Inflamm Bowel Dis"},{"key":"2024021014203442900_jbmr3027-bib-0013","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/MEG.0b013e3282f8888b","article-title":"High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease","volume":"20","author":"Heijckmann","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2024021014203442900_jbmr3027-bib-0014","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/gut.51.5.654","article-title":"High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease","volume":"51","author":"Klaus","year":"2002","journal-title":"Gut"},{"key":"2024021014203442900_jbmr3027-bib-0015","first-page":"721","article-title":"Vertebral fractures and role of low bone mineral density in Crohn's disease","volume":"5","author":"Siffedeen","year":"2007","journal-title":"Gastroenterology"},{"issue":"9","key":"2024021014203442900_jbmr3027-bib-0016","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1572-0241.1998.468_q.x","article-title":"Femoral neck osteopenia in patients with inflammatory bowel disease","volume":"93","author":"Dresner-Pollak","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"2024021014203442900_jbmr3027-bib-0017","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ibd.21349","article-title":"Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends","volume":"17","author":"Benchimol","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"2024021014203442900_jbmr3027-bib-0018","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.gastro.2008.09.072","article-title":"Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease","volume":"136","author":"Dubner","year":"2009","journal-title":"Gastroenterology"},{"key":"2024021014203442900_jbmr3027-bib-0019","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/adc.76.4.325","article-title":"Inflammatory bowel disease and predisposition to osteopenia","volume":"76","author":"Cowan","year":"1997","journal-title":"Arch Dis Child"},{"key":"2024021014203442900_jbmr3027-bib-0020","first-page":"234","article-title":"Inflammatory bone loss: pathogenesis and therapeutic intervention","volume":"11","author":"Redlich","year":"2012","journal-title":"Nat Rev"},{"key":"2024021014203442900_jbmr3027-bib-0021","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1359\/jbmr.2002.17.4.695","article-title":"Effect of Crohn's disease on bone metabolism in vitro: a role for interleukin-6","volume":"17","author":"Sylvester","year":"2002","journal-title":"J Bone Miner Res"},{"key":"2024021014203442900_jbmr3027-bib-0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(03)00841-2","article-title":"Tumor necrosis factor-\u03b1: molecular and cellular mechanisms in skeletal pathology","volume":"321","author":"Nanes","year":"2003","journal-title":"Gene"},{"key":"2024021014203442900_jbmr3027-bib-0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","article-title":"IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathology","volume":"15","author":"Steeve","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"2024021014203442900_jbmr3027-bib-0024","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1054\/ghir.2001.0248","article-title":"Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease","volume":"11","author":"Katsanos","year":"2001","journal-title":"Growth Horm IGF Res"},{"key":"2024021014203442900_jbmr3027-bib-0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cytogfr.2016.02.003","article-title":"The light and the dark sides of Interleukin-10 in immune-mediated diseases and cancer","volume":"30","author":"Geginat","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"2024021014203442900_jbmr3027-bib-0026","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2249.1995.tb03721.x","article-title":"Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD)","volume":"100","author":"Kucharzik","year":"1995","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"2024021014203442900_jbmr3027-bib-0027","doi-asserted-by":"crossref","first-page":"26875","DOI":"10.1155\/MI\/2006\/26875","article-title":"Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase","volume":"2006","author":"Mitsuyama","year":"2006","journal-title":"Mediators Inflamm"},{"key":"2024021014203442900_jbmr3027-bib-0028","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1471-2121-8-4","article-title":"Interleukin-10 inhibits osteoclastogenesis by reducing NFATc1 expression and preventing its translocation to the nucleus","volume":"8","author":"Evans","year":"2007","journal-title":"BMC Cell Biol"},{"key":"2024021014203442900_jbmr3027-bib-0029","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/jcp.1041650321","article-title":"Interleukin-10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast-like cells in rat bone marrow culture system","volume":"165","author":"Xu","year":"1995","journal-title":"Cell Physiol"},{"key":"2024021014203442900_jbmr3027-bib-0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.MIB.0000164015.60795.ca","article-title":"Serum osteoprotegerin is increased in Crohn's disease: a population-based case control study","volume":"11","author":"Bernstein","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2024021014203442900_jbmr3027-bib-0031","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ibd.20234","article-title":"Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy","volume":"13","author":"Miheller","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"2024021014203442900_jbmr3027-bib-0032","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/gut.2004.044370","article-title":"The RANKL\/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss","volume":"54","author":"Moschen","year":"2005","journal-title":"Gut"},{"issue":"2","key":"2024021014203442900_jbmr3027-bib-0033","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jbmr.320","article-title":"The amazing osteocyte","volume":"26","author":"Bonewald","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2024021014203442900_jbmr3027-bib-0034","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jcp.24487","article-title":"TNF-\u03b1 upregulates sclerostin expression in obese mice fed a high-fat diet","volume":"229","author":"Baek","year":"2014","journal-title":"Cell Physiol"},{"issue":"4","key":"2024021014203442900_jbmr3027-bib-0035","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0022034514522485","article-title":"IL-6 alters osteocyte signaling toward osteoblasts but not osteoclasts","volume":"93","author":"Bakker","year":"2014","journal-title":"J Dent Res"},{"issue":"3","key":"2024021014203442900_jbmr3027-bib-0036","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11914-015-0264-1","article-title":"IL-6 and IGF-I within and between muscle and bone: how important is the mTOR pathway for bone metabolism","volume":"13","author":"Bakker","year":"2015","journal-title":"Curr Osteoporos Rep"},{"key":"2024021014203442900_jbmr3027-bib-0037","doi-asserted-by":"crossref","first-page":"E271","DOI":"10.1152\/ajpendo.00092.2013","article-title":"Osteocyte-derived insulin-like growth factor I is essential for determining bone mechanosensitivity","volume":"305","author":"Lau","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2024021014203442900_jbmr3027-bib-0038","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1677\/joe.1.06880","article-title":"Effect of mechanical loading on insulin-like growth factor-I gene expression in rat tibia","volume":"192","author":"Reijnders","year":"2007","journal-title":"J Endocrinol"},{"key":"2024021014203442900_jbmr3027-bib-0039","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bone.2007.09.047","article-title":"Osteocytes as mechanosensors in the inhibition of bone resorption due to mechanical loading","volume":"42","author":"You","year":"2008","journal-title":"Bone"},{"issue":"7","key":"2024021014203442900_jbmr3027-bib-0040","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/MIB.0000000000000402","article-title":"Colonic insult impairs lymph flow, increases cellular content of the lymph, alters local lymphatic microenvironment, and leads to sustained inflammation in the rat ileum","volume":"21","author":"Cromer","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2024021014203442900_jbmr3027-bib-0041","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0016-5085(89)80079-4","article-title":"Hapten-induced model of chronic inflammation and ulceration in the rat colon","volume":"96","author":"Morris","year":"1989","journal-title":"Gastroenterology"},{"issue":"3","key":"2024021014203442900_jbmr3027-bib-0042","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nprot.2007.41","article-title":"Chemically induced mouse models of intestinal inflammation","volume":"2","author":"Wirtz","year":"2007","journal-title":"Nat Protoc"},{"issue":"1","key":"2024021014203442900_jbmr3027-bib-0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1805","article-title":"Standard nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASMBR Histomorphometry Nomenclature Committee","volume":"28","author":"Dempster","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2024021014203442900_jbmr3027-bib-0044","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bone.2008.06.018","article-title":"Dextran sodium sulfate-induced colitis causes rapid bone loss in mice","volume":"43","author":"Hamdani","year":"2008","journal-title":"Bone"},{"key":"2024021014203442900_jbmr3027-bib-0045","doi-asserted-by":"crossref","first-page":"G1020","DOI":"10.1152\/ajpgi.90696.2008","article-title":"Inflammatory bowel disease causes reversible suppression of osteoblast and chondrocyte function in mice","volume":"296","author":"Harris","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2024021014203442900_jbmr3027-bib-0046","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbi.2013.05.005","article-title":"Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitis","volume":"33","author":"Cook","year":"2013","journal-title":"Brain Behav Immun"},{"key":"2024021014203442900_jbmr3027-bib-0047","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.3748\/wjg.v19.i25.3931","article-title":"Why interleukin-10 supplementation does not work in Crohn's disease patients","volume":"19","author":"Gareth","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2024021014203442900_jbmr3027-bib-0048","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/j.gastro.2004.06.013","article-title":"Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones","volume":"127","author":"Dresner-Pollak","year":"2004","journal-title":"Gastroenterology"},{"issue":"5","key":"2024021014203442900_jbmr3027-bib-0049","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S8756-3282(01)00420-3","article-title":"Tumor necrosis factor-\u03b1 cooperates with receptor activator of nuclear factor \u03baB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture","volume":"28","author":"Komine","year":"2001","journal-title":"Bone"},{"key":"2024021014203442900_jbmr3027-bib-0050","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jcb.1202","article-title":"Tumor necrosis factor-\u03b1 mediates RANK ligand stimulation of osteoclast differentiation by an autocrine mechanism","volume":"83","author":"Zou","year":"2001","journal-title":"J Cell Biochem"},{"key":"2024021014203442900_jbmr3027-bib-0051","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1006\/bbrc.1998.9394","article-title":"Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines","volume":"250","author":"Hofbauer","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"2024021014203442900_jbmr3027-bib-0052","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr Rev"},{"key":"2024021014203442900_jbmr3027-bib-0053","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/gut.46.5.695","article-title":"Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis","volume":"46","author":"Ballinger","year":"2000","journal-title":"Gut"},{"issue":"1","key":"2024021014203442900_jbmr3027-bib-0054","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2106\/JBJS.G.01183","article-title":"Osteocyte-derived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling","volume":"90","author":"ten Dijke","year":"2008","journal-title":"J Bone Joint Surg"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.3027","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/32\/4\/802\/56653250\/jbmr3027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/32\/4\/802\/56653250\/jbmr3027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T19:00:37Z","timestamp":1719082837000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/32\/4\/802-813\/7605693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":54,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,10,31]]},"published-print":{"date-parts":[[2017,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.3027","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,4,1]]},"published":{"date-parts":[[2016,10,31]]}}}